Thermo Fisher Scientific (TMO) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Thermo Fisher Scientific · Health Care · ref. ETF XLV · 86 calls · price $663.04
What the company does: Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.
📈 Thermo Fisher Scientific (TMO) stock price
$663.04+26.1% over range
Oct 14, 25low $438.34 · high $679.61Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
73% recommend buying · 11 analysts
📊 JPI status : Thermo Fisher Scientific has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 TMO price target & analyst consensus — price $663
The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$750+13.1%
Median target · of 11 targets$600-9.5%
Lowest target · 1 firm of 11$540-18.6%
Current price$663.04
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
436%
$730 ↔ $760
Below
764%
$540 ↔ $639
⏳ Targets haven't kept up with the price. 73% of ratings say “Buy”, yet 7 of 11 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Barclays — 60% of its targets hit on this sector (645 calls tested). It aims for $750 (+13 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
The 2 reliable analysts
$675+1.8 %
The 9 other firms
$615-7.2 %
How to read it: the 2 reliable firms are not filtered by optimism — 1 aim above the price, 1 below, hence their $675 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy873%
Hold327%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 TMO price target all
All 86 calls, one by one, with our verdict on each firm.
→ See all 86 targets, analyst by analyst💡 The best analysts on TMO most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in TMO? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Thermo Fisher Scientific? The JPI assistant answers using our backtest data.
💰 Thermo Fisher Scientific dividend: yield, history & growth › open the full page
0.35%annual yield
📈 Steady dividend — 8 yrs of consecutive dividend increases
That's ~$1.80 per share per year.
📈 Thermo Fisher Scientific fundamentals: valuation, margins & growth › open the full page
P/E 35.7Net margin 15.0 %Revenue growth +10.5 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 15 %
2023
Rev −5%Profit −14%
2024
Rev +0%Profit +6%
2025
Rev +4%Profit +6%
🔎 Detailed analyses
🏛️ Which US Congress members hold Thermo Fisher Scientific (TMO)?
4 Congress members have disclosed TMO buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on TMO
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| ISI Group | 100% | +61.9% | 4 |
| Jefferies ↗ | 100% | +50.5% | 7 |
| Cantor Fitzgerald ↗ | 100% | +42.4% | 2 |
| Needham ↗ | 100% | +40.6% | 10 |
| Credit Suisse | 100% | +34.6% | 6 |
| Leerink Swann | 100% | +19.0% | 2 |
| UBS ↗ | 91% | +29.7% | 11 |
| Argus Research ↗ | 86% | +18.8% | 7 |
| B of A Securities ↗ | 78% | +11.0% | 18 |
| Morgan Stanley ↗ | 76% | +13.6% | 25 |
See the other 17 firms
| HSBC ↗ | 33% | -15.7% | 3 |
| Cowen & Co. | 33% | -0.5% | 3 |
| Evercore ISI Group ↗ | 43% | -0.4% | 14 |
| TD Cowen ↗ | 50% | -7.2% | 2 |
| SVB Leerink | 50% | +3.2% | 16 |
| RBC Capital ↗ | 57% | +1.7% | 14 |
| JP Morgan ↗ | 60% | +6.8% | 15 |
| Wells Fargo ↗ | 60% | +7.8% | 10 |
| Barclays ↗ | 62% | +11.0% | 26 |
| Deutsche Bank ↗ | 62% | +13.2% | 8 |
| BTIG ↗ | 67% | +14.0% | 9 |
| Baird ↗ | 70% | +12.8% | 30 |
| Raymond James ↗ | 71% | +9.2% | 7 |
| Citigroup ↗ | 71% | +20.7% | 17 |
| Stifel ↗ | 73% | +13.7% | 15 |
| Goldman Sachs ↗ | 75% | +4.2% | 4 |
| Keybanc ↗ | 75% | +9.5% | 4 |
📊 What $1,000 invested in Thermo Fisher Scientific would be worth › open the full page
In short — $1,000 invested in Thermo Fisher Scientific 10 years ago would be worth $3,881 today, i.e. +15%/yr on average. Best year: 2020 (+55%), worst: 2024 (-7%). Price performance, excluding dividends.
If I'd invested $1,000 in Thermo Fisher Scientific
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $948 | -5% |
| 3 years ago | $925 | -7% |
| 5 years ago | $1,114 | +11% |
Return by year (Thermo Fisher Scientific)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -4% | $962 (-4%) |
| 2025 | -1% | $948 (-5%) |
| 2024 | -7% | $879 (-12%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Thermo Fisher Scientific
Loading news…
📋 All analyst calls on TMO
Filtered on — · ✕ show all
Morgan Stanley ↗
Oct 13, 26
▲ Overweight · 🎯$730
Today : $663.04 — upside +10%
🎯 on TMO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Buy · 🎯$760
Today : $663.04 — upside +15%
🎯 on TMO : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Overweight · 🎯$750
Price at call : $651.98 — upside +15%
Today : $663.04 — upside +13%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
CLSA
Sep 3, 26
▲ Outperform · 🎯$748
Price at call : $613.78 — upside +22%
Today : $663.04 — upside +13%
🎯 on TMO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 3, 27
matures : Sep 3, 27
Piper Sandler ↗
Jul 27, 26
■ Neutral neutral · not a buy · 🎯$600
Price at call : $576.41 — gap to target +4%
Today : $663.04 — gap to target -10%
🎯 on TMO : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Morgan Stanley ↗
Jul 27, 26
▲ Overweight · 🎯$650
Price at call : $576.41 — upside +13%
Today : $663.04 — upside -2%
🎯 on TMO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
RBC Capital ↗
Jul 24, 26
■ Sector Perform neutral · not a buy · 🎯$580
Price at call : $559.53 — gap to target +4%
Today : $663.04 — gap to target -13%
🎯 on TMO : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
▲ Overweight · 🎯$650
Price at call : $559.53 — upside +16%
Today : $663.04 — upside -2%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
See the other 78 calls, newest to oldest
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$570
Price at call : $516.62 — upside +10%
Today : $663.04 — upside -14%
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Piper Sandler ↗
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$510
Price at call : $475.66 — gap to target +7%
Today : $663.04 — gap to target -23%
🎯 on TMO : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
■ Hold neutral · not a buy · 🎯$540
Price at call : $482.03 — gap to target +12%
Today : $663.04 — gap to target -19%
🎯 on TMO : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
Wells Fargo ↗
May 8, 26
▲ Overweight · 🎯$615
Price at call : $452.6 — upside +36%
Today : $663.04 — upside -7%
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Buy · 🎯$600
Price at call : $469.71 — upside +28%
Today : $663.04 — upside -10%
🎯 on TMO : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▲ Outperform · 🎯$639
Price at call : $469.71 — upside +36%
Today : $663.04 — upside -4%
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▲ Overweight · 🎯$625
Price at call : $531.67 — upside +18%
Today : $663.04 — upside -6%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$575
Price at call : $489.5 — upside +17%
Today : $663.04 — upside -13%
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Buy · 🎯$685
Price at call : $581.77 — upside +18%
Today : $663.04 — upside +3%
🎯 on TMO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Buy · 🎯$683
Price at call : $581.77 — upside +17%
Today : $663.04 — upside +3%
🎯 on TMO : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Overweight · 🎯$650
Price at call : $581.77 — upside +12%
Today : $663.04 — upside -2%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Buy · 🎯$700
Price at call : $618.86 — upside +13%
Today : $663.04 — upside +6%
🎯 on TMO : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$696
Price at call : $606.5 — upside +15%
Today : $663.04 — upside +5%
🎯 on TMO : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Wells Fargo ↗
Dec 15, 25
▲ Overweight · 🎯$675
Price at call : $570.16 — upside +18%
Today : $663.04 — upside +2%
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Buy · 🎯$660
Price at call : $578.9 — upside +14%
Today : $663.04 — upside -0%
🎯 on TMO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
Goldman Sachs ↗
Dec 9, 25
▲ Buy · 🎯$685
Price at call : $563.07 — upside +22%
Today : $663.04 — upside +3%
🎯 on TMO : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$750
Price at call : $568.21 — upside +32%
Today : $663.04 — upside +13%
🎯 on TMO : no call matured yet · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$670
Price at call : $580.45 — upside +15%
Today : $663.04 — upside +1%
🎯 on TMO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
▲ Buy · 🎯$670
Price at call : $585.15 — upside +15%
Today : $663.04 — upside +1%
🎯 on TMO : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Dec 1, 26
matures : Dec 1, 26
Argus Research ↗
Oct 29, 25
▲ Buy · 🎯$610
Price at call : $556.22 — upside +10%
Today : $663.04 — upside -8%
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
Morgan Stanley ↗
Oct 28, 25
▲ Overweight · 🎯$656
Price at call : $558.31 — upside +17%
Today : $663.04 — upside -1%
🎯 on TMO : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
■ Neutral neutral · not a buy · 🎯$590
Price at call : $572.5 — gap to target +3%
Today : $663.04 — gap to target -11%
🎯 on TMO : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
▲ Buy · 🎯$654
Price at call : $572.5 — upside +14%
Today : $663.04 — upside -1%
🎯 on TMO : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Wells Fargo ↗
Oct 23, 25
▲ Overweight · 🎯$635
Price at call : $571.91 — upside +11%
Today : $663.04 — upside -4%
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
▲ Overweight · 🎯$625
Price at call : $571.91 — upside +9%
Today : $663.04 — upside -6%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
■ Neutral neutral · not a buy · 🎯$580
Price at call : $571.91 — gap to target +1%
Today : $663.04 — gap to target -13%
🎯 on TMO : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Leerink Partners ↗
Oct 22, 25
▲ Outperform · 🎯$580
Price at call : $571.91 — upside +1%
Today : $663.04 — upside -13%
🎯 on TMO : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
▲ Overweight · 🎯$650
Price at call : $534.68 — upside +22%
Today : $663.04 — upside -2%
Expected +22% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
+23.1%
stock +23% · XLV +18%
matured Oct 9, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$590
Price at call : $536.19 — upside +10%
Today : $663.04 — upside -11%
Expected +10% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+21.6%
stock +22% · XLV +16%
matured Oct 7, 26
▲ Overweight · 🎯$585
Price at call : $524.96 — upside +11%
Today : $663.04 — upside -12%
Expected +11% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+24.7%
stock +25% · XLV +16%
matured Oct 2, 26
▲ Overweight · 🎯$550
Price at call : $491.41 — upside +12%
Today : $663.04 — upside -17%
Expected +12% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+24.1%
stock +24% · XLV +18%
matured Sep 11, 26
William Blair ↗
Aug 19, 25
▲ Outperform
Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 64.3% · +7.1% (28 calls)
+23.1%
stock +23% · XLV +28%
matured Aug 19, 26
■ Neutral neutral · not a buy · 🎯$500
Price at call : $478.32 — gap to target +5%
Today : $663.04 — gap to target -25%
🎯 on TMO : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 24, 26
matures : Jul 24, 26
Raymond James ↗
Jul 24, 25
▲ Outperform · 🎯$535
Price at call : $478.32 — upside +12%
Today : $663.04 — upside -19%
Expected +12% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 46.4% · +1.6% (403 calls)
+17.0%
stock +17% · XLV +20%
matured Jul 24, 26
Wells Fargo ↗
Jul 24, 25
▲ Overweight · 🎯$565
Price at call : $475.03 — upside +19%
Today : $663.04 — upside -15%
Expected +19% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 47.6% · +1.0% (403 calls)
+19.6%
stock +20% · XLV +20%
matured Jul 24, 26
■ Equal-Weight neutral · not a buy · 🎯$490
Price at call : $475.03 — gap to target +3%
Today : $663.04 — gap to target -26%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 24, 26
matures : Jul 24, 26
▲ Outperform · 🎯$567
Price at call : $475.03 — upside +19%
Today : $663.04 — upside -14%
Expected +19% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+19.6%
stock +20% · XLV +20%
matured Jul 24, 26
▲ Outperform · 🎯$553
Price at call : $414.75 — upside +33%
Today : $663.04 — upside -17%
Expected +33% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+26.9%
stock +27% · XLV +21%
matured Jul 18, 26
Scotiabank ↗
Jul 11, 25
▲ Sector Outperform · 🎯$590
Price at call : $434.86 — upside +36%
Today : $663.04 — upside -11%
Expected +36% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 100% (1 call matured) · 📊 on Health : 33.3% · -8.8% (9 calls)
+21.5%
stock +22% · XLV +19%
matured Jul 11, 26
■ Neutral neutral · not a buy · 🎯$460
Price at call : $419.88 — gap to target +10%
Today : $663.04 — gap to target -31%
🎯 on TMO : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$480
Price at call : $426.17 — upside +13%
Today : $663.04 — upside -28%
Expected +13% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+19.7%
stock +20% · XLV +20%
matured Jul 8, 26
■ Equal-Weight neutral · not a buy · 🎯$450
Price at call : $410.65 — gap to target +10%
Today : $663.04 — gap to target -32%
🎯 on TMO : 100% (2 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jun 24, 26
matures : Jun 24, 26
Argus Research ↗
Apr 29, 25
▲ Buy · 🎯$470
Price at call : $429 — upside +10%
Today : $663.04 — upside -29%
Expected +10% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+11.7%
stock +12% · XLV +4%
matured Apr 29, 26
Evercore ISI Group ↗
Apr 24, 25
▲ Outperform · 🎯$500
Price at call : $426.66 — upside +17%
Today : $663.04 — upside -25%
Expected +17% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+10.1%
stock +10% · XLV +5%
matured Apr 24, 26
▲ Outperform · 🎯$573
Price at call : $426.66 — upside +34%
Today : $663.04 — upside -14%
Expected +34% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+10.1%
stock +10% · XLV +5%
matured Apr 24, 26
Evercore ISI Group ↗
Oct 24, 24
▲ Outperform · 🎯$620
Price at call : $554.38 — upside +12%
Today : $663.04 — upside -6%
Expected +12% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+1.7%
stock +2% · XLV -1%
matured Oct 24, 25
▲ Outperform · 🎯$622
Price at call : $557.38 — upside +12%
Today : $663.04 — upside -6%
Expected +12% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+2.7%
stock +3% · XLV -2%
matured Oct 24, 25
Evercore ISI Group ↗
Oct 1, 24
▲ Outperform · 🎯$630
Price at call : $612.72 — upside +3%
Today : $663.04 — upside -5%
Expected +3% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-14.3%
stock -14% · XLV -6%
matured Oct 1, 25
▲ Outperform · 🎯$632
Price at call : $594.5 — upside +6%
Today : $663.04 — upside -5%
Expected +6% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-19.5%
stock -20% · XLV -8%
matured Jul 25, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$600
Price at call : $535.61 — upside +12%
Today : $663.04 — upside -10%
Expected +12% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-19.8%
stock -20% · XLV -5%
matured Jul 2, 25
▲ Outperform · 🎯$620
Price at call : $571.73 — upside +8%
Today : $663.04 — upside -6%
Expected +8% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-25.8%
stock -26% · XLV -1%
matured Apr 25, 25
Evercore ISI Group ↗
Apr 4, 24
▲ Outperform · 🎯$610
Price at call : $579.46 — upside +5%
Today : $663.04 — upside -8%
Expected +5% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-24.4%
stock -24% · XLV -6%
matured Apr 4, 25
▲ Outperform · 🎯$670
Price at call : $521.52 — upside +28%
Today : $663.04 — upside +1%
Expected +28% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+1.0%
stock +1% · XLV +4%
matured Dec 13, 24
Argus Research ↗
Nov 6, 23
▲ Buy · 🎯$550
Price at call : $459.24 — upside +20%
Today : $663.04 — upside -17%
Expected +20% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+21.9%
stock +22% · XLV +15%
matured Nov 5, 24
▲ Outperform · 🎯$524
Price at call : $431.41 — upside +21%
Today : $663.04 — upside -21%
Expected +21% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+28.1%
stock +28% · XLV +21%
matured Oct 25, 24
▲ Outperform · 🎯$589
Price at call : $458.26 — upside +29%
Today : $663.04 — upside -11%
Expected +29% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+25.8%
stock +26% · XLV +18%
matured Oct 22, 24
▲ Outperform · 🎯$625
Price at call : $561.85 — upside +11%
Today : $663.04 — upside -6%
Expected +11% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+7.5%
stock +8% · XLV +11%
matured Jul 26, 24
▲ Outperform · 🎯$664
Price at call : $538.27 — upside +23%
Today : $663.04 — upside +0%
Expected +23% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-0.7%
stock -1% · XLV +10%
matured Jul 18, 24
▲ Outperform · 🎯$670
Price at call : $520.64 — upside +29%
Today : $663.04 — upside +1%
Expected +29% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 75% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+12.2%
stock +12% · XLV +13%
matured May 23, 24
Evercore ISI Group ↗
Apr 4, 23
▲ Outperform · 🎯$610
Price at call : $576.18 — upside +6%
Today : $663.04 — upside -8%
Expected +6% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-0.0%
stock -0% · XLV +10%
matured Apr 3, 24
Evercore ISI Group ↗
Feb 1, 23
▲ Outperform · 🎯$615
Price at call : $587.07 — upside +5%
Today : $663.04 — upside -7%
Expected +5% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-6.0%
stock -6% · XLV +7%
matured Feb 1, 24
Evercore ISI Group ↗
Oct 26, 22
▲ Outperform · 🎯$565
Price at call : $498.32 — upside +13%
Today : $663.04 — upside -15%
Expected +13% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-13.4%
stock -13% · XLV -6%
matured Oct 26, 23
Evercore ISI Group ↗
Jul 28, 22
▲ Outperform · 🎯$615
Price at call : $598.41 — upside +3%
Today : $663.04 — upside -7%
Expected +3% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-8.3%
stock -8% · XLV +1%
matured Jul 28, 23
Argus Research ↗
May 27, 22
▲ Buy · 🎯$640
Price at call : $567.57 — upside +13%
Today : $663.04 — upside -3%
Expected +13% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
-9.4%
stock -9% · XLV -4%
matured May 27, 23
Evercore ISI Group ↗
Feb 2, 22
▲ Outperform · 🎯$660
Price at call : $594.93 — upside +11%
Today : $663.04 — upside -0%
Expected +11% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 33% (12 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-1.2%
stock -1% · XLV -0%
matured Feb 2, 23
▲ Buy · 🎯$718
Price at call : $594.93 — upside +21%
Today : $663.04 — upside +8%
Expected +21% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-1.2%
stock -1% · XLV -0%
matured Feb 2, 23
▲ Buy · 🎯$705
Price at call : $635.1 — upside +11%
Today : $663.04 — upside +6%
Expected +11% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-19.1%
stock -19% · XLV -1%
matured Oct 29, 22
▲ Buy · 🎯$700
Price at call : $606.63 — upside +15%
Today : $663.04 — upside +6%
Expected +15% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-14.2%
stock -14% · XLV -6%
matured Sep 22, 22
Argus Research ↗
Aug 4, 21
▲ Buy · 🎯$600
Price at call : $538.88 — upside +11%
Today : $663.04 — upside -10%
Expected +11% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+9.5%
stock +9% · XLV -2%
matured Aug 4, 22
▲ Buy · 🎯$610
Price at call : $540.01 — upside +13%
Today : $663.04 — upside -8%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+9.2%
stock +9% · XLV -1%
matured Jul 29, 22
▲ Buy · 🎯$590
Price at call : $488.96 — upside +21%
Today : $663.04 — upside -11%
Expected +21% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+21.6%
stock +22% · XLV +15%
matured Feb 3, 22
▲ Buy · 🎯$540
Price at call : $480.17 — upside +12%
Today : $663.04 — upside -19%
Expected +12% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+26.6%
stock +27% · XLV +22%
matured Oct 22, 21
Argus Research ↗
Jul 27, 20
▲ Buy · 🎯$450
Price at call : $407.36 — upside +10%
Today : $663.04 — upside -32%
Expected +10% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+29.7%
stock +30% · XLV +25%
matured Jul 27, 21
▲ Buy · 🎯$475
Price at call : $406.38 — upside +17%
Today : $663.04 — upside -28%
Expected +17% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+30.2%
stock +30% · XLV +24%
matured Jul 23, 21
Argus Research ↗
Feb 24, 20
▲ Buy · 🎯$370
Price at call : $309.63 — upside +19%
Today : $663.04 — upside -44%
Expected +19% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+47.5%
stock +47% · XLV +18%
matured Feb 23, 21
▲ Buy · 🎯$372
Price at call : $318.34 — upside +17%
Today : $663.04 — upside -44%
Expected +17% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+61.9%
stock +62% · XLV +15%
matured Jan 30, 21
Argus Research ↗
May 1, 19
▲ Buy · 🎯$310
Price at call : $276.49 — upside +12%
Today : $663.04 — upside -53%
Expected +12% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on TMO : 86% (7 calls matureds) · 📊 on Health : 55.3% · +2.1% (159 calls)
+21.1%
stock +21% · XLV +12%
matured Apr 30, 20
Frequently asked questions
Should I buy Thermo Fisher Scientific stock?
This isn't buy advice. For Thermo Fisher Scientific, the analyst consensus is "Buy", with an average price target of $600 (-10% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Thermo Fisher Scientific). We show the numbers — you decide.
Is it too late to buy Thermo Fisher Scientific? How high can it go?
The most bullish analyst target on Thermo Fisher Scientific is $750 (+13% above today's price); the average is $600. That's the upside they see. Check how reliable those analysts have actually been on Thermo Fisher Scientific on our site before trusting it.
Is Thermo Fisher Scientific still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 27 analysts have a real record on Thermo Fisher Scientific, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Thermo Fisher Scientific? The case for and against
The arguments for and against, one by one, from the numbers: why invest in TMO (and why hesitate).
What has Thermo Fisher Scientific's past performance been?
Historical returns and a "how much if I had invested" calculator: TMO performance & returns.
Does Thermo Fisher Scientific pay a dividend?
Yield, consistency and growth history of the dividend: TMO's dividend.
What is the best month to buy TMO?
The 12 months ranked by the stock's past returns: best & worst month to buy TMO.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX